These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37806122)

  • 21. Optimizing Hybrid Closed-Loop Therapy in Adolescents and Emerging Adults Using the MiniMed 670G System.
    Messer LH; Forlenza GP; Sherr JL; Wadwa RP; Buckingham BA; Weinzimer SA; Maahs DM; Slover RH
    Diabetes Care; 2018 Apr; 41(4):789-796. PubMed ID: 29444895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucose Control Using a Standard Versus an Enhanced Hybrid Closed Loop System: A Randomized Crossover Study.
    Paldus B; Lee MH; Jones HM; McAuley SA; Horsburgh JC; Roem KL; Ward GM; MacIsaac RJ; Cohen N; Colman PG; Jenkins AJ; O'Neal DN
    Diabetes Technol Ther; 2019 Jan; 21(1):56-58. PubMed ID: 30620641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous Glucose Monitors and Activity Trackers to Inform Insulin Dosing in Type 1 Diabetes: The University of Virginia Contribution.
    Fabris C; Ozaslan B; Breton MD
    Sensors (Basel); 2019 Dec; 19(24):. PubMed ID: 31817678
    [No Abstract]   [Full Text] [Related]  

  • 24. Zone model predictive control: a strategy to minimize hyper- and hypoglycemic events.
    Grosman B; Dassau E; Zisser HC; Jovanovic L; Doyle FJ
    J Diabetes Sci Technol; 2010 Jul; 4(4):961-75. PubMed ID: 20663463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier.
    Bruttomesso D; Farret A; Costa S; Marescotti MC; Vettore M; Avogaro A; Tiengo A; Dalla Man C; Place J; Facchinetti A; Guerra S; Magni L; De Nicolao G; Cobelli C; Renard E; Maran A
    J Diabetes Sci Technol; 2009 Sep; 3(5):1014-21. PubMed ID: 20144414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and Feasibility of the OmniPod Hybrid Closed-Loop System in Adult, Adolescent, and Pediatric Patients with Type 1 Diabetes Using a Personalized Model Predictive Control Algorithm.
    Buckingham BA; Forlenza GP; Pinsker JE; Christiansen MP; Wadwa RP; Schneider J; Peyser TA; Dassau E; Lee JB; O'Connor J; Layne JE; Ly TT
    Diabetes Technol Ther; 2018 Apr; 20(4):257-262. PubMed ID: 29431513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of the UVA Simulation Replay Methodology Using Clinical Data: Reproducing a Randomized Clinical Trial.
    Villa-Tamayo MF; Colmegna P; Breton M
    Diabetes Technol Ther; 2024 Oct; 26(10):720-727. PubMed ID: 38662426
    [No Abstract]   [Full Text] [Related]  

  • 28. Glycemic Outcomes in Baseline Hemoglobin A1C Subgroups in the International Diabetes Closed-Loop Trial.
    Ekhlaspour L; Town M; Raghinaru D; Lum JW; Brown SA; Buckingham BA
    Diabetes Technol Ther; 2022 Aug; 24(8):588-591. PubMed ID: 35020488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of 6 months of hybrid closed-loop insulin delivery in adults with type 1 diabetes: a randomised controlled trial protocol.
    McAuley SA; de Bock MI; Sundararajan V; Lee MH; Paldus B; Ambler GR; Bach LA; Burt MG; Cameron FJ; Clarke PM; Cohen ND; Colman PG; Davis EA; Fairchild JM; Hendrieckx C; Holmes-Walker DJ; Horsburgh JC; Jenkins AJ; Kaye J; Keech AC; King BR; Kumareswaran K; MacIsaac RJ; McCallum RW; Nicholas JA; Sims C; Speight J; Stranks SN; Trawley S; Ward GM; Vogrin S; Jones TW; O'Neal DN
    BMJ Open; 2018 Jun; 8(6):e020274. PubMed ID: 29886443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advanced hybrid artificial pancreas system improves on unannounced meal response - In silico comparison to currently available system.
    Garcia-Tirado J; Lv D; Corbett JP; Colmegna P; Breton MD
    Comput Methods Programs Biomed; 2021 Nov; 211():106401. PubMed ID: 34560603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Titration of Long-Acting Insulin Using Continuous Glucose Monitoring and Smart Insulin Pens in Type 1 Diabetes: A Model-Based Carbohydrate-Free Approach.
    El Fathi A; Fabris C; Breton MD
    Front Endocrinol (Lausanne); 2021; 12():795895. PubMed ID: 35082757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.
    Rodbard D
    Diabetes Technol Ther; 2017 Jun; 19(S3):S25-S37. PubMed ID: 28585879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-Effectiveness Analysis of the MiniMed 670G Hybrid Closed-Loop System Versus Continuous Subcutaneous Insulin Infusion for Treatment of Type 1 Diabetes.
    Jendle J; Pöhlmann J; de Portu S; Smith-Palmer J; Roze S
    Diabetes Technol Ther; 2019 Mar; 21(3):110-118. PubMed ID: 30785311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of insulin pumps and closed-loop systems among people living with diabetes: A narrative review of clinical and cost-effectiveness to enable access to technology and meet the needs of payers.
    Jendle J; Reznik Y
    Diabetes Obes Metab; 2023 Jul; 25 Suppl 2():21-32. PubMed ID: 37046364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type-1 Diabetes Patient Decision Simulator for In Silico Testing Safety and Effectiveness of Insulin Treatments.
    Vettoretti M; Facchinetti A; Sparacino G; Cobelli C
    IEEE Trans Biomed Eng; 2018 Jun; 65(6):1281-1290. PubMed ID: 28866479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavioral Patterns and Associations with Glucose Control During 12-Week Randomized Free-Living Clinical Trial of Day and Night Hybrid Closed-Loop Insulin Delivery in Adults with Type 1 Diabetes.
    Emami A; Willinska ME; Thabit H; Leelarathna L; Hartnell S; Dellweg S; Benesch C; Mader JK; Holzer M; Kojzar H; Pieber TR; Arnolds S; Evans ML; Hovorka R
    Diabetes Technol Ther; 2017 Jul; 19(7):433-437. PubMed ID: 28463010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of microdialysis-based continuous glucose monitoring to drive real-time semi-closed-loop insulin infusion.
    Freckmann G; Jendrike N; Pleus S; Buck H; Bousamra S; Galley P; Thukral A; Wagner R; Weinert S; Haug C
    J Diabetes Sci Technol; 2014 Nov; 8(6):1074-80. PubMed ID: 25205589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Basal Glucose Control in Type 1 Diabetes Using Deep Reinforcement Learning: An In Silico Validation.
    Zhu T; Li K; Herrero P; Georgiou P
    IEEE J Biomed Health Inform; 2021 Apr; 25(4):1223-1232. PubMed ID: 32755873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuous Glucose Monitoring and Insulin Informed Advisory System with Automated Titration and Dosing of Insulin Reduces Glucose Variability in Type 1 Diabetes Mellitus.
    Breton MD; Patek SD; Lv D; Schertz E; Robic J; Pinnata J; Kollar L; Barnett C; Wakeman C; Oliveri M; Fabris C; Chernavvsky D; Kovatchev BP; Anderson SM
    Diabetes Technol Ther; 2018 Aug; 20(8):531-540. PubMed ID: 29979618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance of an Automated Insulin Delivery System: Results of Early Phase Feasibility Studies.
    Christiansen M; Bartee A; Lalonde A; Jones RE; Katz M; Wolpert H; Brazg R
    Diabetes Technol Ther; 2021 Mar; 23(3):187-194. PubMed ID: 32940537
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.